This secondary analysis of data from a randomized clinical trial examines differences in outcomes with clinical evaluation and noninvasive testing vs clinical evaluation alone.
This Special Communication discusses the benefits of eliminating creatine kinase–myocardial band testing in suspected acute coronary syndrome.
This study examines the proportion of current patients with acute coronary syndrome in the American College of Cardiology practice innovation and clinical excellence ambulatory cardiology practice registry that would have qualified for the IMPROVE-IT trial, and how their characteristics compared with trial participants.
In this meta-analysis, intra-aortic balloon pump therapy was not found to improve mortality among patients with acute myocardial infarction in randomized clinical trials, regardless of whether patients had cardiogenic shock.
This case series identifies a familial association in spontaneous coronary artery dissection suggesting a genetic predisposition.
This retrospective study of ED visits by adults shows that cardiac biomarker testing in the ED is common even among those without symptoms suggestive of acute coronary syndrome.
Ho and colleagues test a multifaceted intervention to improve cardiac medication regimen adherence and secondary prevention measures. Redberg provides an Editor’s Note.
Cohen et al determined whether a nurse-led or dietician-led cardiovascular risk factor education program would improve risk factor reduction over the long term after an acute coronary syndrome. Patients underwent an education program in a House of Education or were treated according to physicians’ standard of care. See the Invited Commentary by Fihn.
Than and coauthors compared the effectiveness of a rapid diagnostic pathway with a standard-care diagnostic pathway for the assessment of patients with possible cardiac chest pain in a usual clinical practice setting. See also the Invited Commentary by Rahko.
You currently have no searches saved.